rs114115252
×
Entrez Id:
389376
Gene Symbol:
SFTA2
SFTA2
Schizophrenia
0.700
GeneticVariation
GWASCAT
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
28540026
2017
rs114115252
×
Entrez Id:
389376
Gene Symbol:
SFTA2
SFTA2
Child Development Disorders, Pervasive
0.700
GeneticVariation
GWASCAT
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
28540026
2017
rs2253705
×
Entrez Id:
389376
Gene Symbol:
SFTA2
SFTA2
Hepatitis B
0.700
GeneticVariation
GWASDB
A genome-wide association study identified new variants associated with the risk of chronic hepatitis B.
23760081
2013
rs3132581
MUCL3;SFTA2;HCG21
Attention deficit hyperactivity disorder
G
0.800
GeneticVariation
GWASDB
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs3132581
MUCL3;SFTA2;HCG21
Attention deficit hyperactivity disorder
G
0.800
GeneticVariation
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs12190030
MUCL3;SFTA2;HCG21
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
0.700
GeneticVariation
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010
rs12190030
MUCL3;SFTA2;HCG21
HIV-1, RESISTANCE TO
0.700
GeneticVariation
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010
rs12190030
MUCL3;SFTA2;HCG21
AIDS, PROGRESSION TO
0.700
GeneticVariation
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010
rs12190030
MUCL3;SFTA2;HCG21
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
0.700
GeneticVariation
GWASDB
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
21051598
2010
rs2240804
MUCL3;SFTA2;HCG21
Rheumatoid Arthritis
0.700
GeneticVariation
GWASDB
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.
17804836
2007
rs2240804
MUCL3;SFTA2;HCG21
Rheumatoid Arthritis
0.700
GeneticVariation
GWASDB
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.
19503088
2009
rs3132580
MUCL3;SFTA2;HCG21
Malignant neoplasm of lung
0.700
GeneticVariation
GWASDB
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.
22899653
2012
rs3132580
MUCL3;SFTA2;HCG21
Diabetes Mellitus, Insulin-Dependent
0.700
GeneticVariation
GWASDB
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.
17632545
2007
rs3132580
MUCL3;SFTA2;HCG21
Membranous glomerulonephritis
T
0.700
GeneticVariation
GWASCAT
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.
21323541
2011
rs3132580
MUCL3;SFTA2;HCG21
Lupus Erythematosus, Systemic
A
0.700
GeneticVariation
GWASDB
GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region.
24871463
2014
rs3132580
MUCL3;SFTA2;HCG21
Adenocarcinoma of lung (disorder)
0.700
GeneticVariation
GWASDB
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.
19836008
2009
rs3132580
MUCL3;SFTA2;HCG21
Myasthenia Gravis
0.700
GeneticVariation
GWASDB
Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.
23055271
2012
rs3132580
MUCL3;SFTA2;HCG21
Vitiligo
0.700
GeneticVariation
GWASDB
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.
20526339
2010
rs3132581
MUCL3;SFTA2;HCG21
Child Development Disorders, Pervasive
G
0.700
GeneticVariation
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs3132581
MUCL3;SFTA2;HCG21
Bipolar Disorder
G
0.700
GeneticVariation
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs3132581
MUCL3;SFTA2;HCG21
Major Depressive Disorder
G
0.700
GeneticVariation
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs3132581
MUCL3;SFTA2;HCG21
Schizophrenia
G
0.700
GeneticVariation
GWASCAT
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
23453885
2013
rs3757340
MUCL3;SFTA2;HCG21
Rheumatoid Arthritis
0.700
GeneticVariation
GWASDB
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.
19503088
2009
rs2517449
MUCL3;SFTA2;HCG21
Aspirin exacerbated respiratory disease
0.010
GeneticVariation
BEFREE
After testing for multiple comparisons, only the association s ignal from rs2517449 was retained (P(corr) = .04), while other polymorphisms showed no associations with the risk of AERD and FEV(1) decline.
22152429
2012
rs114838832
MUCL3;SFTA2
Schizophrenia
A
0.700
GeneticVariation
GWASCAT
Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia.
28540026
2017